132 related articles for article (PubMed ID: 38745549)
1. Two-Photon Photodegradation of E3 Ubiquitin Ligase Cereblon by a Ru(II) Complex: Inducing Ferroptosis in Cisplatin-Resistant Tumor Cells.
Lin X; Zheng M; Xiong K; Wang F; Chen Y; Ji L; Chao H
J Med Chem; 2024 May; 67(10):8372-8382. PubMed ID: 38745549
[TBL] [Abstract][Full Text] [Related]
2. A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy.
Li J; Zeng L; Xiong K; Rees TW; Jin C; Wu W; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2019 Sep; 55(73):10972-10975. PubMed ID: 31453611
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H
Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487
[TBL] [Abstract][Full Text] [Related]
4. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
[TBL] [Abstract][Full Text] [Related]
5. A Multi-action and Multi-target Ru
Karges J; Yempala T; Tharaud M; Gibson D; Gasser G
Angew Chem Int Ed Engl; 2020 Apr; 59(18):7069-7075. PubMed ID: 32017379
[TBL] [Abstract][Full Text] [Related]
6. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
[TBL] [Abstract][Full Text] [Related]
7. The stepwise photodamage of organelles by two-photon luminescent ruthenium(ii) photosensitizers.
Qiu K; Wen Y; Ouyang C; Liao X; Liu C; Rees TW; Zhang Q; Ji L; Chao H
Chem Commun (Camb); 2019 Sep; 55(75):11235-11238. PubMed ID: 31469153
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy.
Denison M; Garcia SP; Ullrich A; Podgorski I; Gibson H; Turro C; Kodanko JJ
Inorg Chem; 2024 Apr; 63(17):7973-7983. PubMed ID: 38616353
[TBL] [Abstract][Full Text] [Related]
9. Bithiophene-Functionalized Infrared Two-Photon Absorption Metal Complexes as Single-Molecule Platforms for Synergistic Photodynamic, Photothermal, and Chemotherapy.
Li XL; Wang MF; Zeng LZ; Li GK; Zhao RY; Liu FD; Li Y; Yan YF; Liu Q; Li Z; Zhang H; Ren X; Gao F
Angew Chem Int Ed Engl; 2024 Jul; 63(27):e202402028. PubMed ID: 38656658
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents.
Liu J; Chen Y; Li G; Zhang P; Jin C; Zeng L; Ji L; Chao H
Biomaterials; 2015 Jul; 56():140-53. PubMed ID: 25934287
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
Mo J; Mai Le NP; Priefer R
Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
[TBL] [Abstract][Full Text] [Related]
12. Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia.
Liu X; Li G; Xie M; Guo S; Zhao W; Li F; Liu S; Zhao Q
Dalton Trans; 2020 Aug; 49(32):11192-11200. PubMed ID: 32748922
[TBL] [Abstract][Full Text] [Related]
13. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
14. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic antitumor activity of Ru(ii) complexes of imidazo-phenanthroline conjugated hydroxybenzoic acid as tumor targeting photosensitizers.
Liu ZY; Zhang J; Sun YM; Zhu CF; Lu YN; Wu JZ; Li J; Liu HY; Ye Y
J Mater Chem B; 2020 Jan; 8(3):438-446. PubMed ID: 31833531
[TBL] [Abstract][Full Text] [Related]
16. Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway.
Chen L; Wang J; Cai X; Chen S; Zhang J; Li B; Chen W; Guo X; Luo H; Chen J
Bioorg Chem; 2022 Feb; 119():105516. PubMed ID: 34856444
[TBL] [Abstract][Full Text] [Related]
17. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
[TBL] [Abstract][Full Text] [Related]
18. A novel ruthenium polypyridyl complex for the selective imaging and photodynamic targeting of the Golgi apparatus.
Zhao F; Wang W; Wu W
Dalton Trans; 2021 Mar; 50(10):3536-3541. PubMed ID: 33599670
[TBL] [Abstract][Full Text] [Related]
19. Ru(II) Polypyridine Complex-Functionalized Mesoporous Silica Nanoparticles as Photosensitizers for Cancer Targeted Photodynamic Therapy.
Karges J; Díaz-García D; Prashar S; Gómez-Ruiz S; Gasser G
ACS Appl Bio Mater; 2021 May; 4(5):4394-4405. PubMed ID: 35006851
[TBL] [Abstract][Full Text] [Related]
20. Polymeric Encapsulation of a Ruthenium Polypyridine Complex for Tumor Targeted One- and Two-Photon Photodynamic Therapy.
Karges J; Li J; Zeng L; Chao H; Gasser G
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54433-54444. PubMed ID: 33238711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
